This makes Apollo Proton Cancer Centre (APCC) the country'''s first dedicated advanced cancer centre to receive this international accreditation and the eighth hospital in the Group to join the portfolio of JCI accredited hospitals, Apollo Hospitals said in a statement.Read Also: Apollo Hospitals report net profit of Rs 209.60 crore for March quarter
Injectable luteinizing hormone releasing hormone agonists (e.g., leuprolide) are the standard agents for achieving androgen deprivation for prostate cancer despite the initial testosterone surge and delay in therapeutic effect. Relugolix is a novel, oral GnRH receptor antagonist that achieves both LH and FSH suppression to its direct inhibitory effect on the pituitary GnRH receptors. This direct inhibition does not result in a testosterone surge. There no information on the efficacy and safety of relugolix as compared to leuprolide.For the purpose, Neal D. Shore, medical director for the Carolina Urologic Research Center, and colleagues randomly assigned patients with advanced prostate cancer, in a 2:1 ratio, to receive relugolix (120 mg orally once daily) or leuprolide (injections every 3 months) for 48 weeks. A total of 622 patients received relugolix and 308 received leuprolide.
The role of diets in the pathogenesis of cardiac dysfunction is controversial. However, it is well known that Western diet causes oxidative stress and has pro inflammatory effects, whereas Mediterranean style diets are anti inflammatory. Recently, cohort studies and case control studies, have demonstrated that western style diets rich in sugar and physical inactivity with obesity are important behavioural risk factors of heart failure. Pre heart failure may be defined as a state of myocardial dysfunction, which is at high risk for developing complete heart failure. It is similar to pre diabetes or pre hypertension for developing diabetes mellitus and hypertension, respectively.
Researchers at University of Copenhagen have found that fecal transplantation of viruses may decrease weight gain and diabetes risk due to unhealthy lifestyles in obesity in animal studies.
India is a habitat of the world''s largest population of diabetes patients. A large number of these patients are at risk of developing kidney failure as a consequence of the condition. Early detection of diabetes patients at risk of developing kidney disease would help them to take preventive measures against the disease onset.A team of scientists from the National Chemical Laboratory (CSIR NCL) in Pune, researchers from the Madras Diabetes Research Foundation (MDRF) in Chennai, and from the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru aimed to evaluate urinary asymmetric to symmetric dimethylarginine ratio (ASR) for early prediction of diabetic nephropathy (DN).